We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

MorphoSys's Partner Heptares Initiates Proprietary Therapeutic Antibody Program

News   Aug 06, 2015

 
MorphoSys's Partner Heptares Initiates Proprietary Therapeutic Antibody Program
 
 
 

RELATED ARTICLES

Rockland Immunochemicals, Inc. CSO Opines “Benefits of Polyclonal Antibodies” in Peer-reviewed Article

News

Dr. Carl Ascoli, Chief Science Officer at Rockland, and Dr. Birte Aggeler, Director of Antibody Development at Bio-Techne, have composed a review article on the pros and cons of polyclonal, conventional monoclonal, and recombinant monoclonal antibodies.

READ MORE

A Powerful Approach for Stopping Ebola Outbreaks

News

A one-two punch of powerful antibodies may be the best way to stop Ebola virus. Recent findings suggest new therapies should disable Ebola virus’s infection machinery and spark the patient’s immune system to call in reinforcements.

READ MORE

Could a Drug Make Us Drink Less Alcohol?

News

Researchers have developed a new drug that could dampen alcohol’s effects on the brain’s “reward system,” causing rats to self-administer the beverage less frequently.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE